Despite record FII outflows from Indian equities since September 2024, Jefferies said India remains a consensus underweight among emerging ...

The Bank of Japan has increased its policy rate to 1.0 percent. This marks a 31-year high for interest rates. The move signals a strong foc...

Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...

It has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

Indian staffing companies are actively expanding their global reach. They are tapping into international talent shortages across sectors li...

Elivaas, a holiday home operator, is preparing for its next fundraising round to fuel expansion. The company plans to double its villa coun...

Global challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...

Marriott International sees India as a key growth market. The company plans to double its hotel presence in India within five years. This e...

The San Francisco-based company was cofounded by Ashesh Jain, formerly head of autonomy at Lyft's self-driving division, and Peter Ondruska...

Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

Assam is becoming a top live entertainment hub in India. Progressive policies and infrastructure are boosting the economy and tourism. A re...

S&P Global Ratings has declared a Positive outlook for Prism, suggesting a promising trajectory for OYO's parent company. This optimistic a...

Helios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...

Zahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...

To encourage immediate public intervention, the Ministry is introducing the "Rahveer" initiative. "If people step in to rush these 50,000 i...